PMC:7242012 / 7993-8962 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"235","span":{"begin":176,"end":184},"obj":"Species"},{"id":"236","span":{"begin":266,"end":278},"obj":"Disease"},{"id":"237","span":{"begin":287,"end":304},"obj":"Disease"},{"id":"238","span":{"begin":324,"end":346},"obj":"Disease"},{"id":"239","span":{"begin":366,"end":387},"obj":"Disease"},{"id":"240","span":{"begin":415,"end":428},"obj":"Disease"},{"id":"241","span":{"begin":479,"end":488},"obj":"Disease"},{"id":"244","span":{"begin":29,"end":36},"obj":"Species"},{"id":"245","span":{"begin":42,"end":50},"obj":"Disease"}],"attributes":[{"id":"A235","pred":"tao:has_database_id","subj":"235","obj":"Tax:9606"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"MESH:D006973"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"MESH:D003920"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"MESH:D002318"},{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"MESH:D051436"},{"id":"A240","pred":"tao:has_database_id","subj":"240","obj":"MESH:D008107"},{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"MESH:D003643"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"Tax:9606"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T28","span":{"begin":415,"end":420},"obj":"Body_part"}],"attributes":[{"id":"A28","pred":"fma_id","subj":"T28","obj":"http://purl.org/sig/ont/fma/fma7197"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T8","span":{"begin":415,"end":420},"obj":"Body_part"}],"attributes":[{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0002107"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T79","span":{"begin":42,"end":50},"obj":"Disease"},{"id":"T80","span":{"begin":250,"end":257},"obj":"Disease"},{"id":"T81","span":{"begin":266,"end":278},"obj":"Disease"},{"id":"T82","span":{"begin":287,"end":304},"obj":"Disease"},{"id":"T83","span":{"begin":324,"end":346},"obj":"Disease"},{"id":"T84","span":{"begin":366,"end":387},"obj":"Disease"},{"id":"T85","span":{"begin":374,"end":387},"obj":"Disease"},{"id":"T87","span":{"begin":415,"end":428},"obj":"Disease"},{"id":"T88","span":{"begin":744,"end":752},"obj":"Disease"}],"attributes":[{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0011122"},{"id":"A81","pred":"mondo_id","subj":"T81","obj":"http://purl.obolibrary.org/obo/MONDO_0005044"},{"id":"A82","pred":"mondo_id","subj":"T82","obj":"http://purl.obolibrary.org/obo/MONDO_0005015"},{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0004995"},{"id":"A84","pred":"mondo_id","subj":"T84","obj":"http://purl.obolibrary.org/obo/MONDO_0024327"},{"id":"A85","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0002118"},{"id":"A86","pred":"mondo_id","subj":"T85","obj":"http://purl.obolibrary.org/obo/MONDO_0005240"},{"id":"A87","pred":"mondo_id","subj":"T87","obj":"http://purl.obolibrary.org/obo/MONDO_0005154"},{"id":"A88","pred":"mondo_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T72","span":{"begin":231,"end":233},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T73","span":{"begin":236,"end":238},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"},{"id":"T74","span":{"begin":320,"end":322},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T75","span":{"begin":362,"end":364},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T76","span":{"begin":415,"end":420},"obj":"http://purl.obolibrary.org/obo/UBERON_0002107"},{"id":"T77","span":{"begin":415,"end":420},"obj":"http://www.ebi.ac.uk/efo/EFO_0000887"},{"id":"T78","span":{"begin":430,"end":435},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T79","span":{"begin":464,"end":469},"obj":"http://purl.obolibrary.org/obo/CLO_0001313"},{"id":"T80","span":{"begin":559,"end":562},"obj":"http://purl.obolibrary.org/obo/CL_0000990"},{"id":"T81","span":{"begin":636,"end":638},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}

{"project":"LitCovid-sentences","denotations":[{"id":"T96","span":{"begin":0,"end":73},"obj":"Sentence"},{"id":"T97","span":{"begin":74,"end":114},"obj":"Sentence"},{"id":"T98","span":{"begin":115,"end":175},"obj":"Sentence"},{"id":"T99","span":{"begin":176,"end":207},"obj":"Sentence"},{"id":"T100","span":{"begin":208,"end":249},"obj":"Sentence"},{"id":"T101","span":{"begin":250,"end":265},"obj":"Sentence"},{"id":"T102","span":{"begin":266,"end":286},"obj":"Sentence"},{"id":"T103","span":{"begin":287,"end":323},"obj":"Sentence"},{"id":"T104","span":{"begin":324,"end":365},"obj":"Sentence"},{"id":"T105","span":{"begin":366,"end":406},"obj":"Sentence"},{"id":"T106","span":{"begin":407,"end":444},"obj":"Sentence"},{"id":"T107","span":{"begin":445,"end":478},"obj":"Sentence"},{"id":"T108","span":{"begin":479,"end":496},"obj":"Sentence"},{"id":"T109","span":{"begin":497,"end":510},"obj":"Sentence"},{"id":"T110","span":{"begin":511,"end":532},"obj":"Sentence"},{"id":"T111","span":{"begin":533,"end":597},"obj":"Sentence"},{"id":"T112","span":{"begin":598,"end":635},"obj":"Sentence"},{"id":"T113","span":{"begin":636,"end":638},"obj":"Sentence"},{"id":"T114","span":{"begin":639,"end":786},"obj":"Sentence"},{"id":"T115","span":{"begin":787,"end":969},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T27","span":{"begin":250,"end":257},"obj":"Phenotype"},{"id":"T28","span":{"begin":266,"end":278},"obj":"Phenotype"},{"id":"T29","span":{"begin":287,"end":304},"obj":"Phenotype"},{"id":"T30","span":{"begin":324,"end":346},"obj":"Phenotype"},{"id":"T31","span":{"begin":415,"end":428},"obj":"Phenotype"}],"attributes":[{"id":"A27","pred":"hp_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/HP_0001513"},{"id":"A28","pred":"hp_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A29","pred":"hp_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/HP_0000819"},{"id":"A30","pred":"hp_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A31","pred":"hp_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/HP_0001392"}],"text":"Table 2 Comorbidities Among Persons With COVID‐19 Disease, United States\nCondition United States* New York City\nNot Hospitalized Hospitalized Intensive Care Hospitalized\nPatients 5143 1037 457 5700\nOne or more condition 27% 71% 78% 88%\nObesity 42%\nHypertension 57%\nDiabetes mellitus 6% 24% 32% 34%\nCardiovascular disease 5% 23% 29% 18%\nChronic renal disease 1% 9% 12% 0.6%\nChronic liver disease 1% 1% 2% 9%\nImmunocompromised 3% 6% 9% 2%\nMortality 21%\nTotal 21%\n1 Comorbidity 88%\n* Based on data from the CDC for all 50 states and territories. Otherwise, data are Richardson et al. 11\nJohn Wiley \u0026 Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency."}